Mebucaïne Dolo Honig-Zitrone 8.75 mg, Lutschtabletten

7680695180015 CH-69518 Lutschtabletten
Mebucaïne Dolo Honig-Zitrone 8.75 mg, Lutschtabletten
Mebucaïne Dolo Honig-Zitrone 8.75 mg, Lutschtabletten
Mebucaïne Dolo Honig-Zitrone 8.75 mg, Lutschtabletten
1 / 3
google

Article details

Package size
16
Selling units
16
Measure
Tablette(n)
Galenic form
Lutschtabletten
Galenic group
Lutschtabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/02/2025
Patient information leaflet
Français
28/02/2025
Patient information leaflet
Italien
28/02/2025
Summary of Product Characteristics
Allemand
22/01/2025
Summary of Product Characteristics
Français
22/01/2025
Summary of Product Characteristics
Italien
22/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
8.75 MG Substance Wirkstoff (Principe actif)
(N/A)
2051.63 MG Substance HBESI
(N/A)
427.67 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69518
Drug name
Mebucaïne Dolo Honig-Zitrone, Lutschtabletten
Galenic form
LUTT
ATC Code
R02AX01
Authorization status
Z
Dispensing category
D
First authorization
26/08/2024
Authorization expiration date
25/08/2029
IT Number
12.03.2.
Domain
Human medicine
Field of application
Schmerzhafte Entzündungen der Rachenschleimhaut

Package details

Description (FR)
MEBUCAÏNE Dolo cpr sucer 8.75 mg miel citr 16 pce
Description (DE)
MEBUCAÏNE Dolo Lutschtabl 8.75 mg Honig Zit 16 Stk
Market launch
26/08/2024
Narcotic (BTM)
No